868368--12/12/2008--ROCHESTER_MEDICAL_CORPORATION

related topics
{customer, product, revenue}
{property, intellectual, protect}
{product, liability, claim}
{product, market, service}
{operation, international, foreign}
{personnel, key, retain}
{control, financial, internal}
A significant portion of our revenues come from a small number of customers We depend on private label sales arrangements and third party distributors for a significant portion of our revenues, the loss of one or more of which could reduce our future sales revenue We may not succeed in establishing a separate brand identity for our Rochester Medical brand products Our products may not succeed in the market We face significant competition in the market for urinary continence products Our products may become obsolete if we are unable to anticipate and adapt to new treatments or techniques We have a limited history of profitability and may experience future losses Our products and manufacturing activities are subject to extensive governmental regulation that could prevent us from selling our products or introducing new and/or improved products in the United States or internationally Our success may depend on the ability of healthcare providers to achieve adequate levels of third-party reimbursement We depend on certain key personnel, the loss of whom could harm our business We depend on a few suppliers for key components, making us vulnerable to supply shortages and price fluctuation All of our manufacturing operations are conducted at a single industrial park; therefore, any disruption at our existing facilities could substantially affect our business We depend on patents and proprietary rights, which we may not be able to protect We may face intellectual property infringement claims that would be costly to resolve We may face product liability claims that could result in costly litigation and significant liabilities International operations will expose us to additional risks

Full 10-K form ▸

related documents
868368--12/26/2006--ROCHESTER_MEDICAL_CORPORATION
868368--12/4/2007--ROCHESTER_MEDICAL_CORPORATION
868368--12/11/2009--ROCHESTER_MEDICAL_CORPORATION
868368--12/10/2010--ROCHESTER_MEDICAL_CORPORATION
313927--2/24/2009--CHURCH_&_DWIGHT_CO_INC_/DE/
313927--2/24/2010--CHURCH_&_DWIGHT_CO_INC_/DE/
22252--5/3/2010--COMARCO_INC
878725--3/8/2006--EMBREX_INC_/NC/
851205--2/14/2008--COGNEX_CORP
1272547--2/13/2006--FREESCALE_SEMICONDUCTOR_INC
927003--3/28/2006--ADVANCED_ENERGY_INDUSTRIES_INC
1069183--2/29/2008--TASER_INTERNATIONAL_INC
225263--3/11/2008--NEWPORT_CORP
1003113--3/16/2006--MOLECULAR_DEVICES_CORP
1069183--3/15/2007--TASER_INTERNATIONAL_INC
1014507--6/1/2006--SCHICK_TECHNOLOGIES_INC
225263--3/17/2009--NEWPORT_CORP
851205--2/11/2010--COGNEX_CORP
833640--3/8/2007--POWER_INTEGRATIONS_INC
851205--2/17/2009--COGNEX_CORP
103379--3/3/2009--V_F_CORP
772406--5/29/2008--CIRRUS_LOGIC_INC
22252--5/1/2009--COMARCO_INC
712515--5/30/2007--ELECTRONIC_ARTS_INC
1048611--3/15/2006--COLOR_KINETICS_INC
1324759--3/31/2010--Cereplast_Inc
1013606--2/29/2008--ENDOLOGIX_INC_/DE/
833640--3/10/2008--POWER_INTEGRATIONS_INC
1033905--2/25/2010--LUMINEX_CORP
1033905--2/26/2009--LUMINEX_CORP